Differences in interactions of SSRIs

International Clinical Psychopharmacology

Volumn 13, Issue SUPPL. 5, 1998, Pages

  Brosen K ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

CYP1A2; CYP2C19; CYP2C9; CYP2D6; CYP2E1; CYP3A4; Cytochrome P450; Drug drug internctions

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CITALOPRAM; CLOZAPINE; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DICLOFENAC; DRUG METABOLIZING ENZYME; FLUOXETINE; FLUVOXAMINE; MEPHENYTOIN; METHOXSALEN; MOCLOBEMIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORCITALOPRAM; OLANZAPINE; OPIATE; PAROXETINE; PHENYTOIN; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TACRINE; THEOPHYLLINE; TOLBUTAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; WARFARIN;

CONFERENCE PAPER; DRUG ELIMINATION; DRUG OXIDATION; ENZYME INHIBITION; PRIORITY JOURNAL;

EID: 0031689096     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199809005-00009     Document Type: Conference Paper

References (3)

1. Brøsen K and Buur Rasmussen B (1996). Selective serotonin reuptake inhibitors: Pharmacokinetics and drug interactions. In Selective serotonin re-uptake inhibitors. Advances in basic research and clinical practice, Second edition. (Feighner J and Boyer WP eds.) UK: John Wiley&Sons. pp. 87-108.
2. Hallas J (1995). Drug related hospital admissions in subspecialities of internal medicine. Doctoral Thesis, Odense University, Denmark. Lœgeforeningens Forlag, Copenhagen, Denmark.
3. Jeppesen U, Buur Rasmussen B and Brøsen K (1997). Fluvoxamine inhibits the CYP2C19 catalyzed bioactivation of proguanil. Clin Pharmacol Ther 62:279-86.